breaking news1278

In a recent study, scientists used machine learning to create a unique COVID-19 vaccine that targets the stimulation of T cells and is intended to be a pan-variant vaccine...

The antibodies produced by your initial COVID vaccination or infection may adversely impact later booster injections, according to recent research...

Vaccinations that offer long-lasting protection against influenza, coronaviruses, and respiratory syncytial virus (RSV) have been challenging to create; recent research has now investigated the problems and outlined alternatives to better…

In a recent paper, researchers have found that immunisation with the Moderna COVID-19 mRNA vaccine at different times of the day has no effect on the efficacy of the vaccine...

In this study, Ebenig and colleagues were able to come up with a detailed description of what they believe to be the immune-cell mediated mechanisms responsible for inducing Vaccine-associated enhanced…

In a new study, researchers have looked at the primary site of SARS-CoV-2 infection and done T-cell analysis of nasal swab samples to assess immunity following vaccination and infection...

In a recent paper, researchers described the effects and role of CD8+ T-cell responses following vaccination with Ad26.COV2.S (Janssen/Johnson & Johnson) in the response against SARS-CoV-2 infection utilising a rhesus…

Hans-Martin, et al., reported the isolation of monoclonal antibodies from TRIANNI mice, which can be used to provide a pair of non-competing human monoclonal antibodies for clinical development...